• Dig Liver Dis · Apr 2015

    Editorial

    FOLFIRI+bevacizumab induction chemotherapy followed by bevacizumab or observation in metastatic colorectal cancer, a phase III trial (PRODIGE 9--FFCD 0802).

    • Thomas Aparicio, Benjamin Linot, Karine Le Malicot, Olivier Bouché, Valérie Boige, Eric François, Francois Ghiringhelli, Jean-Louis Legoux, Meher Ben Abdelghani, Jean-Marc Phelip, Roger Faroux, Laetitia Dahan, Julien Taieb, and Laurent Bedenne.
    • Department of Gastroenterology, Avicenne Hospital, Bobigny, France. Electronic address: thomas.aparicio@avc.aphp.fr.
    • Dig Liver Dis. 2015 Apr 1; 47 (4): 271-2.

    no abstract available

      Pubmed     Full text   Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?

    User can't be blank.

    Content can't be blank.

    Content is too short (minimum is 15 characters).

    300 characters remaining
    help        
    You can also include formatting, links, images and footnotes in your notes
    • Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
    • Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
    • Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
    • Links can be included with: [my link to pubmed](http://pubmed.com)
    • Images can be included with: ![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
    • For footnotes use [^1](This is a footnote.) inline.
    • Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..

    hide…